🇧🇪 Belgium Country × Condition
breast cancer Clinical Trials in Belgium
Active clinical trials for breast cancer with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇧🇪 Belgium
Active Trials in Belgium (5)
NCT04531696
Recruiting
UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research
Enrollment
100 pts
Country
🇧🇪 Belgium
Universitaire Ziekenhuizen KU Leuve...
View Trial → NCT05123482 Phase 1, Phase 2
Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Enrollment
460 pts
Country
🇧🇪 Belgium
AstraZeneca
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇧🇪 Belgium
UMC Utrecht
View Trial → NCT06146231
Recruiting
Motiva Flora® Aesthetic Breast Recon® Clinical Study
Enrollment
66 pts
Country
🇧🇪 Belgium
Establishment Labs
View Trial → NCT05867966
Recruiting
Psychoneurological Symptom Cluster in Oncology
Enrollment
500 pts
Country
🇧🇪 Belgium
University of Liege
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in Belgium?
There are currently 5 active clinical trials for breast cancer with sites in Belgium, of which 5 are actively recruiting patients.
How can I join a breast cancer clinical trial in Belgium?
To join a breast cancer clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Belgium?
Active breast cancer trials in Belgium span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology